Celgene, Sanofi Executives Charged With Insider Trading

Executives at Celgene Corp., Sanofi and Stryker Corp. were among six people charged for their roles in a health-care stock insider-trading ring that prosecutors said generated $1.48 million in illicit profit.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.